CAML — Central Asia Metals PLC
Executive summary
CAML is an AIM-listed base metals producer with two cash-generative operations: the low-cost Kounrad SX-EW copper project in Kazakhstan (2025 EBITDA margin 75%, C1 $0.82/lb — bottom quartile globally) and the Sasa zinc-lead mine in North Macedonia. Operating trajectory 2020-2025 shows steady copper output (~13-14ktpa) but structurally declining zinc/lead grades at Sasa, culminating in a $117.5m non-cash impairment at year-end 2025 as management shortened Sasa's mine life from 2039 to 2034 2026-03 FY25 results. The single most important valuation point today is that the shares (146p, £263m market cap) trade on a mid-single-digit P/E and ~3× 2026E FCF at record copper prices, but the announced all-scrip acquisition of Cygnus Metals (June 2026, 30% dilution for a pre-development asset in Quebec) materially clouds the near-term investment case.
Fair value estimate
Range: 170p – 230p per share, implying £290m – £390m market cap.
Methodology: sum-of-parts of two producing assets plus balance sheet, cross-checked against P/FCF and management's own recoverable-value calculations.
- Kounrad: 2025 EBITDA $97m, 9-year remaining life to 2034, low country risk premium since Kazakh currency devaluation cushions costs — NPV c. $300-400m at 10% real discount
- Sasa: Management's own 2025 impairment test valued Sasa CGU at $258m (recoverable amount, using long-term Zn $3,366/t, Pb $2,353/t, 9.95% discount) 2026-03 FY25 results, Note 19
- Net cash / working capital: c. $80m
- Corporate overheads/exploration: -$20m/year × 6-year DCF horizon = -$120m
- Total: c. $520-620m = £395-470m pre-Cygnus. On the current 170m share count that's 232-276p; the Cygnus scheme (79m new shares issued for A$232m = £120m of pre-development optionality) is roughly neutral to marginally dilutive, bringing per-share NAV back into a 170-230p range on the enlarged 249m share count.
Vs current market cap of £263m: 10% – 48% upside (midpoint 200p = 37% upside).
Sector context
Basic Materials / Basic Resources — small-cap base metals mining. This is textbook cyclical mining exposure. CAML's quality profile is above typical peers on cost curve position (Kounrad bottom quartile), balance sheet (net cash vs sector-average net debt) and dividend track record ($420m returned since 2010 IPO). Below typical peers on scale, mine life (both assets deplete within ~10 years) and geographic diversification (though the Cygnus deal begins to address the last point). Listed peers: Central Asia Metals sits between the larger LSE-listed base metals names (e.g. Antofagasta, Kaz Minerals when listed) and AIM juniors like Atalaya Mining, Serabi Gold. Closest cost-curve/scale comparable is probably Atalaya Mining.
Investment thesis
- Structurally low-cost copper at Kounrad captures record copper prices with high margin flow-through. H1 2026 average received copper price of $13,076/t vs $9,377/t in H1 2025, and management flagged "H1 2026 shaping up to be a highly profitable and cash-generative period" 2026-06 trading update. On broker consensus copper prices of $10,000+/t and Kounrad's C1 of $0.82/lb, Kounrad alone generates ~$80-100m annual EBITDA against a group EV of ~£200m.
- Debt-free balance sheet with $80m cash plus continued FCF generation provides both downside protection and optionality. Group ended 2025 with $80m cash and $0.9m overdraft 2026-03 FY25 results. This has funded both the failed NWR bid (from which CAML received a break fee and sold NWR shares at profit) and the recent Cygnus scheme. Dividend policy of 30-50% of FCF is intact.
- Copper exposure aligns with structural electrification and data centre buildout demand. Management explicitly cited "infrastructure for artificial intelligence" as a driver of the copper price rally in 2025 2026-03 FY25 results, Financial Review. This is indirect AI exposure but a real supply-constrained commodity story.
Key risks
- Sasa mine life re-rating risk. Management cut LOM from 2039 to 2034 at year-end 2025 based on updated NSR cut-offs and cost inflation, triggering $117.5m impairment 2026-03 FY25 results. Head grades have deteriorated (Zn 2.61% in 2025 vs 3.15% in 2022; Pb 3.35% vs 3.63%). Further downgrades cannot be ruled out.
- Cygnus/Chibougamau execution risk. All-scrip acquisition of a pre-development asset whose 2022 PEA is "at scoping study level only" with 66% of production target underpinned by Inferred Resources 2026-06 Cygnus announcement. Requires updated PEA, feasibility study, permitting and financing before contributing to cash flow — years away, and dilutes current shareholders 30%.
- Commodity price cyclicality and Kounrad depletion. Both mines are finite (both ~9 years remaining). 2026 Kounrad guidance is 12-13kt vs 13.3kt in 2025 — production is drifting lower as fresh dump material is exhausted. Any correction from current record copper prices would materially reduce cash generation.
Operating leverage
CAML has moderate-to-good operating leverage but volume-capped. At Kounrad, the fixed-cost base (labour ~15% of C1, admin, sustaining capex) means incremental copper price flows through at ~90%+ contribution margin — hence 2025 EBITDA margin of 75% at Kounrad. The 2025 sensitivity disclosure indicates a 10% commodity price move = $22m EBITDA change 2026-03 FY25 results, Note 4. So a 10-20% price beat = 20-45% EBITDA uplift, which is meaningful but not multiples-of-profit territory. The critical constraint is that volumes cannot expand — Kounrad guidance is already declining, and Sasa is throughput-limited at ~800ktpa. Unlike a software company with spare capacity, CAML cannot deliver a demand-driven volume surge. This is classic price-taking miner leverage: powerful within a 10-20% band around consensus, but with no operational scalability. The Chibougamau asset, if built, would add ~30kt copper-equivalent per year — but that's late 2020s / early 2030s.
Value-trap signals
- Dividend cut from 18p (2024) to 12p (2025) — management framed this as returning to policy after a period above policy, but still a signal that capital is being reallocated to acquisitions
- Sasa impairment and mine-life reduction — the second material downward re-rating of Sasa reserves under CAML ownership (prior $34m Sasa mineral rights impairment in 2022)
- Depleting asset base — both mines have ~9 years remaining life; without Chibougamau or a further acquisition, CAML is a slowly liquidating cash flow stream
- Repeated dilution risk from M&A — NWR bid failed after being outbid; Cygnus deal completes with 30% dilution for pre-development optionality
- Complex Cygnus structure with 12% investor already backing a Kinterra alternative; shareholder approval risk
Earnings vs expectations
Track record is mixed. 2025 Sasa production guidance was cut mid-year (July 2025) as head grades disappointed, with zinc and lead output landing at the lower end of revised guidance 2025-09 interim results. Kounrad has consistently met or exceeded copper guidance every year 2021-2025. 2025 Group EBITDA of $101.8m was essentially flat on 2024 ($102.4m restated) despite higher metal prices, indicating operating cost pressure kept a lid on the price benefit. H1 2026 trading update indicates production is ahead of the corresponding 2025 periods for all three metals 2026-06 trading update, suggesting the enhanced-safety-driven operational headwinds at Sasa are moderating. Pattern: Kounrad reliable, Sasa volatile; consensus modest beats on the copper side, occasional misses on the zinc/lead side.
Conviction
Conviction: 3 (moderate). Anchoring factors: (1) Kounrad's genuinely low-cost position and clean historical disclosure make the copper cash flow relatively easy to model; (2) net cash balance sheet is unambiguous; (3) commodity prices are directly observable and management publishes production guidance annually. Limiting factors: (1) the Sasa impairment demonstrates that mine life estimates carry meaningful uncertainty, and further downgrades are possible; (2) the Cygnus acquisition is not yet closed (September 2026 scheme meeting), and the value of the Chibougamau optionality is genuinely difficult to pin — a wide range of outcomes for a pre-feasibility asset with a lapsed PEA.